Amendment to Schedule 13D Filing for Core Scientific, Inc.

This filing is an amendment to a Schedule 13D for Core Scientific, Inc. Two Seas Capital LP (TSC) has entered into a cooperation agreement with the Issuer. Pursuant to this agreement, the Issuer will appoint three independent directors by September 2027, in consultation with TSC. Additionally, one current director will not be nominated for re-election in 2027, and the current Chairman of the Board, Jordan Levy, will not stand for re-election in 2026. The agreement includes customary standstill provisions, restricting TSC from acquiring more than 9.9% of the outstanding Common Stock, and requires TSC to vote in accordance with the Board's recommendations at the 2026 and 2027 annual meetings. The filing details transactions of Common Stock and stock options by TSC and its associated funds between January 20, 2026, and February 19, 2026. As of February 19, 2026, TSC and its affiliates beneficially owned approximately 6.7% of Core Scientific, Inc.'s outstanding Common Stock.